Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 902748, 5 pages
http://dx.doi.org/10.1155/2014/902748
Research Article

Oxidative Status and Acute Phase Reactants in Patients with Environmental Asbestos Exposure and Mesothelioma

1Department of Pulmonary Diseases, School of Medicine , Dicle University, 21280 Diyarbakir, Turkey
2Department of Biochemistry, School of Medicine, Dicle University, 21280 Diyarbakir, Turkey

Received 28 August 2013; Accepted 19 November 2013; Published 23 January 2014

Academic Editors: E. Hopper-Borge, N. Sunaga, and J. Thrasher

Copyright © 2014 Cengizhan Sezgi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. T. Mossman and A. Churg, “Mechanisms in the pathogenesis of asbestosis and silicosis,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1666–1680, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. M. W. Janssen, J. P. Marsh, M. P. Absher et al., “Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica,” The Journal of Biological Chemistry, vol. 267, no. 15, pp. 10625–10630, 1992. View at Google Scholar · View at Scopus
  3. S. Sarban, A. Kocyigit, M. Yazar, and U. E. Isikan, “Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis,” Clinical Biochemistry, vol. 38, no. 11, pp. 981–986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Blokhina and K. V. Fagerstedt, “Oxidative metabolism, ROS and NO under oxygen deprivation,” Plant Physiology and Biochemistry, vol. 48, no. 5, pp. 359–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Matsuzaki, M. Maeda, S. Lee et al., “Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 492608, 9 pages, 2012. View at Publisher · View at Google Scholar
  6. Y. M. W. Janssen, J. P. Marsh, M. P. Absher et al., “Oxidant stress responses in human pleural mesothelial cells exposed to asbestos,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 795–802, 1994. View at Google Scholar · View at Scopus
  7. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Philip, D. A. Rowley, and H. Schreiber, “Inflammation as a tumor promoter in cancer induction,” Seminars in Cancer Biology, vol. 14, no. 6, pp. 433–439, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. C. Robinson and L. M. Coussens, “Soluble mediators of inflammation during tumor development,” Advances in Cancer Research, vol. 93, pp. 159–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Federico, F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio, “Chronic inflammation and oxidative stress in human carcinogenesis,” International Journal of Cancer, vol. 121, no. 11, pp. 2381–2386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. E. Craighead, J. L. Abraham, A. Churg et al., “The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health,” Archives of Pathology and Laboratory Medicine, vol. 106, no. 11, pp. 544–596, 1982. View at Google Scholar · View at Scopus
  13. C. B. Manning, V. Vallyathan, and B. T. Mossman, “Diseases caused by asbestos: mechanisms of injury and disease development,” International Immunopharmacology, vol. 2, no. 2-3, pp. 191–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. V. L. Kinnula and J. D. Crapo, “Superoxide dismutases in the lung and human lung diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 12, pp. 1600–1619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Matsuzaki, M. Maeda, S. Lee et al., “Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 492608, 9 pages, 2012. View at Publisher · View at Google Scholar
  16. H. Osada and T. Takahashi, “Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer,” Oncogene, vol. 21, no. 48, pp. 7421–7434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Syslová, P. Kacer, M. Kuzma et al., “Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases,” Journal of Chromatography B, vol. 877, no. 24, pp. 2477–2486, 2009. View at Publisher · View at Google Scholar
  18. A. C. Tanrikulu, A. Abakay, M. A. Kaplan et al., “A Clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma,” Respiration, vol. 80, no. 6, pp. 480–487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Abu-Youssef, S. Amin, H. Amin, and E. Osman, “Value of C-reactive protein in etiologic diagnosıs of pleural effusion,” The Egyptian Journal of Bronchology, vol. 4, pp. 124–130, 2010. View at Google Scholar
  20. S. Nojiri, K. Gemba, K. Aoe et al., “Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan,” Japanese Journal of Clinical Oncology, vol. 41, no. 1, pp. 32–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. D. Chan, G. B. Pott, P. E. Silkoff, A. H. Ralston, C. L. Bryan, and L. Shapiro, “Alpha-1-antitrypsin inhibits nitric oxide production,” Journal of leukocyte biology, vol. 92, no. 6, pp. 1251–1260, 2012. View at Publisher · View at Google Scholar
  22. M. S. Huuskonen, J. A. Räsänen, H. Härkönen, and S. Asp, “Asbestos exposure as a cause of immunological stimulation,” Scandinavian Journal of Respiratory Diseases, vol. 59, no. 6, pp. 326–332, 1978. View at Google Scholar · View at Scopus
  23. M. Kasprzyk, W. Dyszkiewicz, D. Zwaruń, S. Szydlik, K. Leśniewska, and M. Krzyzanowski, “The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC),” Przegļd Lekarski, vol. 63, no. 10, pp. 936–940, 2006. View at Google Scholar · View at Scopus
  24. C. Wu, C. Chen, Y. Yang, C. Hao, J. Ni, and D. Che, “Relationship between the expression of alpha 1-antitrypsinase in bronchioalveolar carcinoma and clinical pathology,” Journal of Tongji Medical University, vol. 20, no. 1, pp. 26–28, 2000. View at Google Scholar · View at Scopus
  25. A. Yıldırım, M. Meral, H. Kaynar, H. Polat, and E. Y. Uçar, “Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer,” Medical Science Monitor, vol. 13, no. 4, pp. CR195–CR200, 2007. View at Google Scholar · View at Scopus
  26. N. Milman and L. M. Pedersen, “The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer,” Oncology Reports, vol. 9, no. 1, pp. 193–198, 2002. View at Google Scholar · View at Scopus
  27. F. Kuralay, Z. Tokgöz, and A. Cömlekci, “Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin,” Clinica Chimica Acta, vol. 300, no. 1-2, pp. 43–55, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hasegawa, M. Koshikawa, I. Takahashi et al., “Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells,” Journal of Trace Elements in Medicine and Biology, vol. 22, no. 3, pp. 248–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. H. Shannahan, O. Alzate, W. M. Winnik et al., “Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposure,” Toxicology and Applied Pharmacology, vol. 260, no. 2, pp. 105–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Scanni, L. Licciardello, M. Trovato, M. Tomirotti, and M. Biraghi, “Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung,” Tumori, vol. 63, no. 2, pp. 175–180, 1977. View at Google Scholar · View at Scopus
  31. P. Knekt, A. Aromaa, J. Maatela et al., “Serum ceruloplasmin and the risk of cancer in Finland,” British Journal of Cancer, vol. 65, no. 2, pp. 292–296, 1992. View at Google Scholar · View at Scopus